{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:00:01Z","timestamp":1790341201090,"version":"4.1.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/cid\/ciag461","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:17:32Z","timestamp":1785323852000},"source":"Crossref","is-referenced-by-count":0,"title":["Protecting the Gut Microbiome When Treating Bloodstream Infections: The Price of Anaerobic Coverage"],"prefix":"10.1093","author":[{"given":"Aryna","family":"Kolodyazhna","sequence":"first","affiliation":[{"name":"Center for Infection and Molecular Medicine, Amsterdam University Medical Center (Amsterdam UMC) , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2277-1343","authenticated-orcid":false,"given":"Willem Joost","family":"Wiersinga","sequence":"additional","affiliation":[{"name":"Center for Infection and Molecular Medicine, Amsterdam University Medical Center (Amsterdam UMC) , Amsterdam ,","place":["The Netherlands"]},{"name":"Department of Medicine, Division of Infectious Diseases, Amsterdam UMC , Amsterdam ,","place":["The Netherlands"]},{"name":"Amsterdam Institute for Infection and Immunity (AII), Amsterdam UMC , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"2026092508061051000_ciag461-B1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41579-025-01183-w","article-title":"Gut microbiota-derived short-chain fatty acids and their role in human health and disease","volume":"23","author":"Mukhopadhya","year":"2025","journal-title":"Nat Rev Microbiol"},{"key":"2026092508061051000_ciag461-B2","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.cmi.2026.02.016","article-title":"Dynamics of the gut and lung microbiota in severe infections: from observational studies to therapeutic strategies","volume":"32","author":"de Gaay Fortman","year":"2026","journal-title":"Clin Microbiol Infect"},{"key":"2026092508061051000_ciag461-B3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/gutjnl-2015-309728","article-title":"The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia","volume":"65","author":"Schuijt","year":"2016","journal-title":"Gut"},{"key":"2026092508061051000_ciag461-B4","doi-asserted-by":"crossref","first-page":"100864","DOI":"10.1016\/S2666-5247(24)00079-X","article-title":"Association between butyrate-producing gut bacteria and the risk of infectious disease hospitalisation: results from two observational, population-based microbiome studies","volume":"5","author":"Kullberg","year":"2024","journal-title":"Lancet Microbe"},{"key":"2026092508061051000_ciag461-B5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1164\/rccm.201503-0483OC","article-title":"Hospitalization type and subsequent severe sepsis","volume":"192","author":"Prescott","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026092508061051000_ciag461-B6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13054-020-02989-1","article-title":"The gut microbiome's role in the development, maintenance, and outcomes of sepsis","volume":"24","author":"Adelman","year":"2020","journal-title":"Crit Care"},{"key":"2026092508061051000_ciag461-B7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s12975-020-00863-4","article-title":"Disruptions of anaerobic gut bacteria are associated with stroke and post-stroke infection: a prospective case-control study","volume":"12","author":"Haak","year":"2021","journal-title":"Transl Stroke Res"},{"key":"2026092508061051000_ciag461-B8","doi-asserted-by":"crossref","first-page":"2200910","DOI":"10.1183\/13993003.00910-2022","article-title":"In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes","volume":"61","author":"Chanderraj","year":"2023","journal-title":"Eur Respir J"},{"key":"2026092508061051000_ciag461-B9","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00199-16","article-title":"Extreme dysbiosis of the microbiome in critical illness","volume":"1","author":"McDonald","year":"2016","journal-title":"mSphere"},{"key":"2026092508061051000_ciag461-B10","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2020.2717","article-title":"Prevalence and outcomes of infection among patients in intensive care units in 2017","volume":"323","author":"Vincent","year":"2020","journal-title":"JAMA"},{"key":"2026092508061051000_ciag461-B11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/CCM.0000000000007089","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2026","volume":"54","author":"Prescott","year":"2026","journal-title":"Crit Care Med"},{"key":"2026092508061051000_ciag461-B12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciag460","article-title":"Association of anti-anaerobic antibiotics with mortality and the gut microbiome: a substudy of the BALANCE randomized clinical trial","author":"Armstrong","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026092508061051000_ciag461-B13","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMoa2404991","article-title":"Antibiotic treatment for 7 versus 14 days in patients with bloodstream infections","volume":"392","author":"BALANCE Investigators, for the Canadian Critical Care Trials Group; the Association of Medical Microbiology and Infectious Disease Canada Clinical Research Network","year":"2025","journal-title":"N Engl J Med"},{"key":"2026092508061051000_ciag461-B14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.immuni.2018.12.018","article-title":"The short chain fatty acid butyrate imprints an antimicrobial program in macrophages","volume":"50","author":"Schulthess","year":"2019","journal-title":"Immunity"},{"key":"2026092508061051000_ciag461-B15","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","article-title":"Interaction between drugs and the gut microbiome","volume":"69","author":"Weersma","year":"2020","journal-title":"Gut"},{"key":"2026092508061051000_ciag461-B16","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41586-025-09273-8","article-title":"Identification of medication-microbiome interactions that affect gut infection","volume":"644","author":"Kumar","year":"2025","journal-title":"Nature"},{"key":"2026092508061051000_ciag461-B17","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria","volume":"555","author":"Maier","year":"2018","journal-title":"Nature"},{"key":"2026092508061051000_ciag461-B18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S2213-2600(24)00257-1","article-title":"Empirical antibiotic therapy for sepsis: save the anaerobic microbiota","volume":"13","author":"Kullberg","year":"2025","journal-title":"Lancet Respir Med"},{"key":"2026092508061051000_ciag461-B19","doi-asserted-by":"crossref","first-page":"RP97751","DOI":"10.7554\/eLife.97751.3","article-title":"The impact of different antimicrobial exposures on the gut microbiome in the ARMORD observational study","volume":"13","author":"Peto","year":"2025","journal-title":"eLife"},{"key":"2026092508061051000_ciag461-B20","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02244-18","article-title":"Ceftriaxone and cefotaxime have similar effects on the intestinal Microbiota in human volunteers treated by standard-dose regimens","volume":"63","author":"Burdet","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2026092508061051000_ciag461-B21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1198-743x.2001.00264.x","article-title":"Effect of step-down therapy of ceftriaxone plus loracarbef versus parenteral therapy of ceftriaxone on the intestinal microflora in patients with community-acquired pneumonia","volume":"7","author":"Vogel","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"2026092508061051000_ciag461-B22","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jamainternmed.2024.0581","article-title":"Mortality of patients with sepsis administered piperacillin-tazobactam vs cefepime","volume":"184","author":"Chanderraj","year":"2024","journal-title":"JAMA Intern Med"},{"key":"2026092508061051000_ciag461-B23","doi-asserted-by":"crossref","first-page":"2300413","DOI":"10.1183\/13993003.00413-2023","article-title":"Empiric anti-anaerobic antibiotics are associated with adverse clinical outcomes in emergency department patients","volume":"61","author":"Kullberg","year":"2023","journal-title":"Eur Respir J"},{"key":"2026092508061051000_ciag461-B24","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.2023.20583","article-title":"Cefepime vs piperacillin-tazobactam in adults hospitalized with acute infection: the ACORN randomized clinical trial","volume":"330","author":"Qian","year":"2023","journal-title":"JAMA"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag461\/70475940\/ciag461.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag461\/70475940\/ciag461.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:06:19Z","timestamp":1790337979000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/advance-article\/doi\/10.1093\/cid\/ciag461\/8750769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":24,"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag461","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"article-number":"ciag461"}}